Skip to main content
. 2013 May 20;1(4):599–609. doi: 10.3892/mco.2013.124

Table IV.

Status of the immunohistochemical staining profiling of the confirmed proteins, CD10, desmin and β-catenin in patients with ESS.

Proteins Endometrial stromal nodules Low-grade ESS Undifferentiated endometrial sarcomas Cellular leiomyomata
CD10 2+ 1+ 0 to 1+ 0
Desmin 0 to 1+ 0 to 1+ 0 to 1+ 2+
β-catenin 2+ 2+ 1+ 0

The expression of each protein was investigated by immunohistochemical staining. Due to the low incidence of endometrial stromal sarcoma (ESS), a combination of staining profiling data was obtained from several studies.